Session Details

F030 Autoimmune Blistering Diseases: What's New?

Fri, Mar 8, 3:30 PM - 5:30 PM
Room 7B
2 CME Available Forum
View Map

DESCRIPTION

Open admission to eligible categories, no tuition or ticket

This session will focus on new advances in AIBD regarding causation of pemphigus, pemphigoid and EBA, along with evidence based treatment and new therapies in the pipeline for pemphigus and pemphigoid.

LEARNING OBJECTIVES

1.

Identify why people get pemphigus and pemphigoid, shorten the time to diagnose a blistering disease, recognize if certain drugs may have triggered the disease to cease them and select the best treatment for the patient with pemphigus and pemphigoid.

2.

Discuss the evidence behind current treatments for pemphigus, bullous pemphigoid and EBA.

3.

Describe new therapies in the pipeline for pemphigoid and pemphigus.

SCHEDULE

11:30 PM

Introduction to all speakers and topics

Dedee F. Murrell, MD, FAAD

11:35 PM

Who develops pemphigus and why?

Eli Sprecher, MD, PhD, IFAAD

11:55 PM

New treatments in the pipeline for pemphigus

Dedee F. Murrell, MD, FAAD

12:15 AM

Rationale for the treatment of bullous pemphigoid

Pascal Joly, MD, PhD, IFAAD

12:35 AM

New treatments in the pipeline for bullous pemphigoid

Aikaterini Patsatsi, MD, PhD, IFAAD

12:55 AM

Epidermolysis bullosa acquisita- what's new

Frederic Caux, PhD

1:15 AM

Q and A

SPEAKERS

Frederic Caux, PhD

Frederic Caux, PhD

Pascal Joly, MD, PhD, IFAAD

Pascal Joly, MD, PhD, IFAAD

Dedee F. Murrell, MD, FAAD

Dedee F. Murrell, MD, FAAD

Aikaterini Patsatsi, MD, PhD, IFAAD

Aikaterini Patsatsi, MD, PhD, IFAAD

Eli Sprecher, MD, PhD, IFAAD

Eli Sprecher, MD, PhD, IFAAD

HANDOUTS

Login to view handouts

SPEAKER DISCLOSURES

Frederic Caux, PhD

arGEN-X – Advisory Board(Honoraria), Investigator(Fees); Boehringer Ingelheim – Advisory Board(Honoraria); LEO Laboratories Ltd (LEO Pharma) – Speaker(Honoraria); Regeneron – Investigator(Fees); Sanofi – Speaker(Fees);

Pascal Joly, MD, PhD, IFAAD

Amgen – Consultant(Honoraria), Consultant (1099 relationship)(Honoraria); arGEN-X – Consultant(Honoraria); AstraZeneca – Consultant(Honoraria); GlaxoSmithKline – Consultant(Honoraria); Lilly ICOS LLC – Consultant(Honoraria); Novartis Pharmaceuticals Corp. – Consultant(Honoraria); Principia Biopharma Inc – Consultant(Honoraria); Roche Laboratories – Consultant(Honoraria); sanofi-aventis – Consultant(Honoraria); TOPAZ Pharmaceuticals, Inc. – Consultant(Honoraria);

Dedee F. Murrell, MD, FAAD

Abbott Laboratories – Advisory Board(Honoraria), Speaker(Honoraria); AbbVie – Investigator(Grants/Research Funding); Actavis – Speaker/Faculty Education(Honoraria); Almirall – Consultant(Honoraria); Amgen – Investigator(Fees); Amicus Therapeutics – Advisory Board(Honoraria); Anacor Pharmaceuticals, Inc. – Investigator(Grants/Research Funding); Arena Pharmaceuticals – Investigator(Grants/Research Funding); arGEN-X – Investigator(Fees); Ascent Pharmaceuticals – Speaker(Honoraria); Castle Creek Pharmaceuticals – Consultant(Fees); CSL – Speaker(Grants/Research Funding), Speaker(Honoraria); Delfin Technology – Investigator(Equipment); Eli Lilly and Company – Advisory Board(Honoraria); Galderma Laboratories, L.P. – Investigator(Grants/Research Funding), Investigator(Other Financial Benefit); Janssen-Ortho Inc. – Other(Grants/Research Funding); Leo Pharma Inc – Speaker/Faculty Education(Honoraria); Medimmune – Investigator(Grants/Research Funding); Merck Serono – Investigator(Fees), Investigator(Grants/Research Funding); Molynlycke – Speaker(Grants/Research Funding); Novartis Pharmaceuticals Corp. – Advisory Board(Honoraria), Investigator(Grants/Research Funding); Pfizer Inc. – Investigator(Grants/Research Funding); Pierre Fabre Dermo-Cosmétique US – Speaker(Honoraria); Principia Biopharma Inc – Consultant(Honoraria); Roche Laboratories – Advisory Board(Honoraria), Investigator(Grants/Research Funding); Samumed, LLC – Investigator(Grants/Research Funding); Sanofi – Advisory Board(Fees), Investigator(Fees), Investigator(Grants/Research Funding); Schering-Plough Corporation – Investigator(Grants/Research Funding), Speaker(Other Financial Benefit); Shire – Advisory Board(Honoraria), Investigator(Grants/Research Funding); Stiefel a GSK company – Speaker(Honoraria); XOMA (US) LLC – Investigator(Grants/Research Funding);

Aikaterini Patsatsi, MD, PhD, IFAAD

AbbVie – Speaker(Honoraria); Argenx – Advisory Board(Honoraria); Janssen Pharmaceuticals, Inc – Speaker(Honoraria); Leo Pharma Inc – Speaker(Honoraria); Novartis Hellas – Speaker(Honoraria); Pfizer Inc. – Advisory Board(Honoraria); Pharmaserv Lilly – Speaker(Honoraria); Sanofi – Advisory Board(Honoraria), Speaker(Honoraria); UCB – Speaker(Honoraria);

Eli Sprecher, MD, PhD, IFAAD

Amryt Pharma – Consultant (1099 relationship)(Fees); Bayer – Consultant (1099 relationship)(Fees); BiomX Ltd. – Consultant (1099 relationship)(Fees); BiondVax Pharmaceuticals – Consultant (1099 relationship)(Fees); Galmed Pharmaceuticals – Consultant (1099 relationship)(Fees); I-DERM, NGT HealthCare2 – Consultant (1099 relationship)(Fees); Kamari Pharma – Consultant (1099 relationship)(Fees); Krystal Biotech, Inc – Consultant (1099 relationship)(Fees); Laser team – Consultant (1099 relationship)(Fees); Medison Pharma – Consultant (1099 relationship)(Fees); Pincell – Consultant (1099 relationship)(No Compensation Received); Sol-Gel Technologies – Consultant (1099 relationship)(Equipment);